In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Determining Factors Which Contribute to Clopidogrel Resistance in Patients Undergoing Endovascular Stent Placement for Unruptured Aneurysm Treatment

    Final Number:
    1128

    Authors:
    Alexandra Rose Paul; Constantine E. Plakas MD; M. Reid Gooch MD; John C. Dalfino MD; Junichi Yamamoto MD, PhD; Alan S. Boulos MD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2015 Annual Meeting

    Introduction: Advances in endovascular technology have allowed for the treatment of previously untreatable aneurysms, often with the aid of a stent, which requires dual antiplatelet therapy. Resistance to clopidogrel has been well documented in the cardiology literature but remains controversial in neuroendovascular. The cardiology literature suggests that men and women may have a different response to clopidogrel and that younger women are more likely to be resistant.

    Methods: We retrospectively reviewed the charts of 26 patients who underwent placement on a LVIS Jr stent, 17 patients who underwent placement of a pipeline stent and 12 patients who underwent placement of a FRED stent for elective treatment of unruptured aneurysms. The first pretreatment PRU was recorded as well as any additional measurements. A nonresponder was defined as a patient with a PRU>240 on the first assessment. An overresponder was defined as a patient with a PRU<50. The widest interval between PRU measurements was also recorded.

    Results: No male patients were found to be nonresponders to clopidogrel compared to 7 females(p=0.32). There was a trend toward higher PRU in females compared to males(153 vs 118, p=0.2). In addition, female patients tended to have a wider fluctuation in PRU compared to male patients(95 versus 61, p=0.36), although not statistically significant.Two ischemic complications and one hemorrhagic complication were noted.

    Conclusions: Dual antiplatelet therapy is becoming more common with advances in endovascular technology which allow for placement of stents in smaller vessels. Understanding the variability in response to clopidogrel will be essential in decreasing complications including post-operative ischemic events as well as symptomatic intracranial hemorrhage.

    Patient Care: The importance of determining a patient's response to clopidogrel is well established in the cardiology literature and our series suggests it may also be related to both ischemic and hemorrhagic complications in patients who undergo stent placement for unruptured aneurysms.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) Describe the importance of understand clopidogrel reactivity in the endovascular patient population 2) Discuss several factors which may play a role in determining reactivity and fluctuations in the same patient.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy